Skip to content

Long-term Prognosis in Stroke Patients

Long-term Prognosis in Stroke Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03510312
Enrollment
9000
Registered
2018-04-27
Start date
2011-12-31
Completion date
2021-12-31
Last updated
2021-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Stroke

Brief summary

A single-center cohort of patients with acute ischemic stroke and transient ischemic attack who admitted to the Severance hospital of Yonsei university and their long-term outcomes.

Detailed description

This is a single-center cohort of consecutive patients with acute ischemic stroke and transient ischemic attack who admitted to the Severance hospital of Yonsei university in Republic of Korea. Stroke recurrence, Cardiovascular event, all cause mortality and cardiovascular mortality were collected through long-term follow up.

Interventions

None listed

Sponsors

Severance Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients with acute ischemic stroke or transient ischemic attack

Exclusion criteria

* A patient who did not agree with enrollment of this study

Design outcomes

Primary

MeasureTime frameDescription
Event of Stroke or transient ischemic attackthrough study completion, up to 10 yearsThe time of a stroke or transient ischemic attack occurs (through study completion)
Event of cardiovascular disease (include stroke/transient ischemic attack)through study completion, up to 10 yearsThe time of a cardiovascular disease (stroke/transient ischemic attack) occurs (through study completion)
All cause mortalitythrough study completion, up to 10 yearsThe time of death from any cause (through study completion)
Cardiovascular cause mortality (include stroke/transient ischemic attack mortality)through study completion, up to 10 yearsThe time of death from cardiovascular cause (through study completion)
The modified Rankin Scale (mRS)3 monthsMeasure functional outcome as the form of mRS at 3 months

Countries

South Korea

Contacts

Primary ContactJi Hoe Heo, MD, PhD
jhheo@yuhs.ac82-2-2228-1605

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026